evogene(evgn):孕婦保健
孕婦保健描述::Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003357 Act: 34 Size: 10 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003434 Act: 34 Size: 7 MB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003232 Act: 34 Size: 20 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-002895 Act: 34 Size: 420 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003628 Act: 34 Size: 34 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003286 Act: 34 Size: 504 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003441 Act: 34 Size: 11 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-002773 Act: 34 Size: 287 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-002656 Act: 34 Size: 26 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003978 Act: 34 Size: 4 MB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003805 Act: 34 Size: 27 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003479 Act: 34 Size: 33 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003421 Act: 34 Size: 10 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003152 Act: 34 Size: 252 KB 網頁鏈接
Evogene(EVGN):
本輪募集資金將主要用于:完成腫瘤免疫項目BMC128的一期臨床研究,并推進到二期臨床試驗;完成并擴大針對炎癥性腸病(IBD)的BMC333項目的GMP生產,并為BMC333的一期臨床試驗進行準備工作;以及推進其他研發計劃。 以色... 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004291 Act: 34 Size: 23 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004079 Act: 34 Size: 504 KB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003341 Act: 34 Size: 5 MB 網頁鏈接
Evogene(EVGN):
Evogene(EVGN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003910 Act: 34 Size: 11 KB 網頁鏈接